Search results
Rockville cancer therapy company set to IPO this week - Washington Business Journal
The Business Journals· 4 days agoOS Therapies Inc., a Rockville biotech advancing a treatment for a rare cancer plaguing kids, is...
Decades of gene therapy research pay off big for Madison company
Wisconsin State Journal· 2 days ago“From the very start, we wanted to focus on gene therapy,” said Jim Hagstrom, a molecular biologist...
US FDA clears Kyverna’s KYV-101 cell therapy for Phase II SPS trial
Clinical Trials Arena via Yahoo Finance· 1 day agoKYV-101 is an autologous, fully human anti-CD19 CAR T-cell product candidate designed for use in...
Investigative Sickle Cell gene therapy patient advocates for change on Capitol Hill
WJW via Yahoo News· 1 day ago22-year-old Canaan Evans has been living with Sickle Cell disease his entire life, but thanks to a...
Rachel Leviss Tried a 'Mormon Church' in Search of Her 'Higher Power' After Looking to Men for...
People via Yahoo News· 7 hours agoIn the latest episode of her podcast, Rachel Goes Rogue, the Vanderpump Rules alum discussed her...
US FDA approves expanded use of Sarepta's Duchenne gene therapy
Reuters· 2 days ago, opens new tab gene therapy for all patients with Duchenne muscular dystrophy aged four and above...
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy...
Morningstar· 3 days agoAurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001 First allogeneic ...
Intra-Cellular Therapies (NASDAQ:ITCI) PT Raised to $94.00 at Needham & Company LLC
ETF DAILY NEWS· 2 days agoIntra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) had its price objective raised by investment analysts at Needham & Company LLC from $90.00 to $94.00 in a report released on Tuesday, ...
Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression
Clinical Trials Arena via Yahoo Finance· 4 days agoIntra-Cellular Therapies has secured another win with positive topline results from a Phase III...
APAC leaps ahead in adoptive cell therapy space
Clinical Trials Arena via Yahoo Finance· 5 days agoThe Asia Pacific (APAC) region is leading the charge for adoptive cell therapy studies, says Scotty Chung-Siu, a managing analyst at GlobalData. At the...